Sentiment Trading

Ventyx Biosciences expands its Scientific Advisory Board, positioning itself as a forward-thinking entity in the biotechnology sector with potential to make significant contributions to healthcare.

Ventyx Biosciences, a biotech company focused on autoimmune disease treatments, has expanded its advisory board and continues to navigate market fluctuations with a market capitalization of $98.2 million.